ADAMS, ROBYN
56
Betreute Anmeldungen
Technische BereichePatente
Biotechnologie51
Pharmazeutika11
Organische Feinchemie1
Grundsätzliche Werkstoffchemie1

Heimatländer der Klienten

Zusammenfassung

ADAMS, Robyn ist besonders erfahren in den Technologien „Biotechnologie“ und „Pharmazeutika“. 95% aller Patente wurden im Bereich „(Bio-)Chemie“ betreut. Die wichtigsten Klienten sind „ZYMOGENETICS, INC.“ und „NATIONAL JEWISH MEDICAL AND RESEARCH CENTER“. Besonders viele Patentanmeldungen wurden in den Jahren 2001 und 2002 betreut. Die Klienten stammen oftmals aus USA.

Patente nach Jahren

Patente nach Bereichen

53
Patentanmeldungen

Patente nach Anmeldern

RangNameLandPatente
1ZYMOGENETICS, INC.Australien55
2NATIONAL JEWISH MEDICAL AND RESEARCH CENTERUSA2
3METHEOR THERAPEUTICS CORPORATIONUSA1

Letzte Anmeldungen

PublikationsnummerTitelPatentanmelderJahr
WO2014011573OLIGONUCLEOTIDE INHIBITORS OF DNA METHYLTRANSFERASES AND THEIR USE IN TREATING DISEASESMETHEOR THERAPEUTICS CORPORATION
2014
WO2009151460METHODS OF CONVERTING FAB SEQUENCES INTO SINGLE CHAIN ANTIBODY SEQUENCESZYMOGENETICS, INC.
2009
WO2009082624ANTAGONISTS OF IL-17A, IL-17F, AND IL-23 AND METHODS OF USING THE SAMEZYMOGENETICS, INC.
2009
WO2008133684ANTIBODIES THAT BIND BOTH IL-17A AND IL-17F AND METHODS OF USING THE SAMEZYMOGENETICS, INC.
2008
WO2008134659ANTAGONISTS TO IL-17A, IL-17F, AND IL-23P19 AND METHODS OF USEZYMOGENETICS, INC.
2008
WO2008086505METHODS OF USING IL-31 TO TREAT AIRWAY HYPER-RESPONSIVENESS AND ASTHMAZYMOGENETICS, INC.
2008
WO2008039553SOLUBLE IL-17RCX4 AND METHODS OF USING IN INFLAMMATIONZYMOGENETICS, INC.
2008
WO2008028192VARIABLE REGION SEQUENCES OF IL-31 MONOCLONAL ANTIBODIES AND METHODS OF USEZYMOGENETICS, INC.
2008
WO2007149981METHODS OF GENE EXPRESSION ANALYSISZYMOGENETICS, INC.
2007
WO2007147019IL-17 AND IL-23 ANTAGONISTS AND METHODS OF USING THE SAMEZYMOGENETICS, INC.
2007
WO2007143231METHODS OF TREATING PAIN AND INFLAMMATION IN NEURONAL TISSUE USING IL-31 ANTAGONISTSZYMOGENETICS, INC.
2007
WO2007133816METHODS OF TREATING PAIN AND INFLAMMATION IN NEURONAL TISSUE USING IL-31RA AND OSMRB ANTAGONISTSZYMOGENETICS, INC.
2007
WO2007033140PROK2 ANTAGONISTS AND METHODS OF USEZYMOGENETICS, INC.
2007
WO2007005320METHODS OF DELIVERING CORTICOTROPH-DERIVED GLYCOPROTEIN HORMONEZYMOGENETICS, INC.
2007
WO2006122060COMPOSITIONS AND USES OF SECRETED POLYPEPTIDE, ZSIG98ZYMOGENETICS, INC.
2006
WO2006122079IL-31 MONOCLONAL ANTIBODIES AND METHODS OF USEZYMOGENETICS, INC.
2006
WO2006088955METHODS OF TREATING DISEASES WHICH ARE MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE CELLSNATIONAL JEWISH MEDICAL AND RESEARCH CENTER
ZYMOGENETICS, INC.
2006
WO2006088956METHODS OF PREDICTING THERPEUTIC RESPONSE IN ATOPIC DERMATITIS TO IL-31 ANTAGONISTSNATIONAL JEWISH MEDICAL AND RESEARCH CENTER
ZYMOGENETICS, INC.
2006
WO2006081573HOMOGENEOUS PREPARATIONS OF IL-31ZYMOGENETICS, INC.
2006
WO2005087256USE OF CORTICOTROPH-DERIVCED GLYCOPROTEIN HORMONE TO TREAT LIVER STEATOSISZYMOGENETICS, INC.
2005
WO2005058952ZTNF13, A TUMOR NECROSIS FACTORZYMOGENETICS, INC.
2005
WO2005058957ZTNF 12, A TUMOR NECROSIS FACTORZYMOGENETICS, INC.
2005
WO2005056046METHODS FOR TREATING INFLAMMATION USING THYROID STIMULATING HORMONEZYMOGENETICS, INC.
2005
WO2005051994ZTNF11, A TUMOR NECROSIS FACTORZYMOGENETICS, INC.
2005
WO2004078947USE OF THYROID-STIMULATING HORMONE TO INDUCE LIPOLYSISZYMOGENETICS, INC.
2004